# Thermo Fisher Scientific to acquire Clario Holdings for $8.875B

Thermo Fisher Scientific agreed to acquire Clario Holdings, a provider of endpoint data solutions for clinical trials, from a shareholder group led by Astorg and Nordic Capital, Novo Holding and Cinven, for $8.875 billion in cash at close plus potential earnout payments.

- Type: Acquisition
- Announced: 2025-10-29
- Where: United States
- Value: $8.88B
- Status: announced
- Products: clinical trial endpoint data solutions, electronic clinical outcome assessments, medical imaging, cardiac solutions, respiratory assessments, wearable data capture technologies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Nordic Capital](https://endata.com/companies/623.md) (investor)
- [Astorg](https://endata.com/companies/3555.md) (investor)
- [Thermo Fisher Scientific](https://endata.com/companies/7061.md) (acquirer)
- [Cinven](https://endata.com/companies/23050.md) (investor)
- [Novo Holdings](https://endata.com/companies/82631.md) (investor)
- [Clario Holdings](https://endata.com/companies/88128.md) (target)

## Sources

- [ir.thermofisher.com](https://ir.thermofisher.com/investors/news-events/news/news-details/2025/Thermo-Fisher-Scientific-to-Acquire-Clario-Holdings-Inc--Enabling-Pharma-and-Biotech-Customers-to-Accelerate-Innovation-with-Deeper-Clinical-Insights/default.aspx), 2025-10-29: "Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced a definitive agreement to acquire Clario Holdings, Inc."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.